The linear ubiquitin chain assembly complex regulates TRAIL‐induced gene activation and cell death

Élodie Lafont(CRUK Lung Cancer Centre of Excellence), Chahrazade Kantari‐Mimoun(CRUK Lung Cancer Centre of Excellence), Peter Dráber(CRUK Lung Cancer Centre of Excellence), Diego de Miguel(CRUK Lung Cancer Centre of Excellence), Torsten Hartwig(CRUK Lung Cancer Centre of Excellence), Matthias Reichert(CRUK Lung Cancer Centre of Excellence), Sebastian Kupka(CRUK Lung Cancer Centre of Excellence), Yutaka Shimizu(CRUK Lung Cancer Centre of Excellence), Lucia Taraborrelli(CRUK Lung Cancer Centre of Excellence), Maureen Spit(CRUK Lung Cancer Centre of Excellence), Martin R. Sprick(Heidelberg Institute for Stem Cell Technology and Experimental Medicine), Henning Walczak(CRUK Lung Cancer Centre of Excellence)
The EMBO Journal
March 3, 2017
Cited by 108Open Access
Full Text

Abstract

LUBAC is a crucial component of various immune receptor signalling pathways. Here, we show that LUBAC forms part of the TRAIL-R-associated complex I as well as of the cytoplasmic TRAIL-induced complex II In both of these complexes, HOIP limits caspase-8 activity and, consequently, apoptosis whilst being itself cleaved in a caspase-8-dependent manner. Yet, by limiting the formation of a RIPK1/RIPK3/MLKL-containing complex, LUBAC also restricts TRAIL-induced necroptosis. We identify RIPK1 and caspase-8 as linearly ubiquitinated targets of LUBAC following TRAIL stimulation. Contrary to its role in preventing TRAIL-induced RIPK1-independent apoptosis, HOIP presence, but not its activity, is required for preventing necroptosis. By promoting recruitment of the IKK complex to complex I, LUBAC also promotes TRAIL-induced activation of NF-κB and, consequently, the production of cytokines, downstream of FADD, caspase-8 and cIAP1/2. Hence, LUBAC controls the TRAIL signalling outcome from complex I and II, two platforms which both trigger cell death and gene activation.


Related Papers

No related papers found

Powered by citation graph analysis